Plain-English translation of NCT07149714 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a temporary heart support device called the iVAC 2L to help patients with severe coronary artery disease undergo a risky heart artery procedure called percutaneous coronary intervention (PCI). The device pumps blood from your heart during and shortly after the procedure to keep you stable and reduce the risk of heart failure or other serious complications.
Currently, many patients with severe coronary artery disease who are too sick or high-risk for open-heart surgery have limited options. This trial exists to see if using temporary mechanical heart support during the procedure can make this less-risky procedure safer and more effective for these vulnerable patients.
You likely qualify if…
You likely don't qualify if…
You will be admitted to the hospital where your heart team will evaluate your condition with heart imaging, blood tests, and risk assessment. Then you will be taken to a special operating room where doctors will place the iVAC 2L device through a small catheter in your groin artery, positioning it to support your heart during your coronary procedure. The device will be removed shortly after the procedure once your heart is stable enough.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Russia